Moody Lynn & Lieberson, LLC Pfizer Inc Transaction History

Moody Lynn & Lieberson, LLC

$1.54 Billion
Q4 2024

A detailed history of Moody Lynn & Lieberson, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Moody Lynn & Lieberson, LLC holds 51,700 shares of PFE stock, worth $1.35 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

51,700

Previous 83,153 37.83%

Holding current value

$1.35 Million

Previous $2.41 Million 43.02%

% of portfolio

0.09%

Previous 0.16%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 21, 2025	SELL	$24.8 - $30.19 $780,034 - $949,566	-31,453 Reduced 37.83%	51,700 $1.37 Million
Q3 2024 Oct 23, 2024	BUY	$27.7 - $31.39 $753,384 - $853,745	27,198 Added 48.61%	83,153 $2.41 Million
Q2 2024 Jul 25, 2024	BUY	$25.26 - $29.6 $334,644 - $392,140	13,248 Added 31.02%	55,955 $1.57 Million
Q1 2024 Apr 23, 2024	SELL	$25.89 - $29.73 $64,725 - $74,325	-2,500 Reduced 5.53%	42,707 $1.19 Million
Q4 2023 Jan 24, 2024	SELL	$26.13 - $33.94 $342,721 - $445,157	-13,116 Reduced 22.49%	45,207 $1.3 Million
Q3 2023 Oct 24, 2023	SELL	$32.09 - $37.51 $370,158 - $432,677	-11,535 Reduced 16.51%	58,323 $1.93 Million
Q2 2023 Jul 27, 2023	SELL	$36.12 - $41.79 $8.79 Million - $10.2 Million	-243,388 Reduced 77.7%	69,858 $2.56 Million
Q1 2023 May 02, 2023	SELL	$39.39 - $51.28 $956,113 - $1.24 Million	-24,273 Reduced 7.19%	313,246 $12.8 Million
Q4 2022 Feb 01, 2023	SELL	$41.75 - $54.5 $652,260 - $851,453	-15,623 Reduced 4.42%	337,519 $17.3 Million
Q3 2022 Oct 26, 2022	SELL	$43.76 - $53.42 $4.01 Million - $4.89 Million	-91,626 Reduced 20.6%	353,142 $15.5 Million
Q2 2022 Jul 28, 2022	BUY	$46.53 - $55.17 $2.03 Million - $2.4 Million	43,527 Added 10.85%	444,768 $23.3 Million
Q1 2022 Apr 27, 2022	SELL	$45.75 - $56.69 $83,265 - $103,175	-1,820 Reduced 0.45%	401,241 $20.8 Million
Q4 2021 Jan 26, 2022	BUY	$41.32 - $61.25 $7.19 Million - $10.7 Million	174,008 Added 75.97%	403,061 $23.8 Million
Q3 2021 Oct 26, 2021	BUY	$39.25 - $50.42 $3.95 Million - $5.07 Million	100,594 Added 78.31%	229,053 $9.85 Million
Q2 2021 Jul 28, 2021	BUY	$35.91 - $40.68 $609,284 - $690,217	16,967 Added 15.22%	128,459 $5.03 Million
Q1 2021 Apr 23, 2021	BUY	$33.49 - $37.77 $293,271 - $330,751	8,757 Added 8.52%	111,492 $4.04 Million
Q4 2020 Jan 26, 2021	BUY	$33.47 - $42.56 $717,395 - $912,231	21,434 Added 26.36%	102,735 $3.78 Million
Q3 2020 Oct 28, 2020	BUY	$31.75 - $37.25 $142,779 - $167,513	4,497 Added 5.86%	81,301 $2.98 Million
Q2 2020 Jul 24, 2020	BUY	$30.12 - $36.54 $248,580 - $301,564	8,253 Added 12.04%	76,804 $2.51 Million
Q1 2020 Apr 30, 2020	BUY	$27.03 - $38.62 $574,765 - $821,215	21,264 Added 44.97%	68,551 $2.24 Million
Q4 2019 Jan 28, 2020	SELL	$32.92 - $37.36 $12,114 - $13,748	-368 Reduced 0.77%	47,287 $1.85 Million
Q3 2019 Oct 28, 2019	BUY	$32.49 - $42.13 $9,909 - $12,849	305 Added 0.64%	47,655 $1.71 Million
Q2 2019 Jul 23, 2019	SELL	$36.98 - $41.52 $15,235 - $17,106	-412 Reduced 0.86%	47,350 $2.05 Million
Q1 2019 Apr 23, 2019	BUY	$37.5 - $41.2 $4,050 - $4,449	108 Added 0.23%	47,762 $2.03 Million
Q4 2018 Jan 29, 2019	BUY	$38.47 - $43.86 $25,082 - $28,596	652 Added 1.39%	47,654 $2.08 Million
Q3 2018 Oct 29, 2018	SELL	$34.47 - $41.81 $7,583 - $9,198	-220 Reduced 0.47%	47,002 $2.07 Million
Q2 2018 Jul 24, 2018	BUY	$32.98 - $35.16 $146,464 - $156,145	4,441 Added 10.38%	47,222 $1.71 Million
Q1 2018 Apr 27, 2018	BUY	$31.91 - $37.02 $59,671 - $69,227	1,870 Added 4.57%	42,781 $1.52 Million
Q4 2017 Feb 02, 2018	SELL	$33.26 - $35.29 $1,529 - $1,623	-46 Reduced 0.11%	40,911 $1.55 Million
Q3 2017 Nov 06, 2017	BUY	$31.0 - $34.15 $1.27 Million - $1.4 Million	40,957	40,957 $1.46 Million

Others Institutions Holding PFE

# of Institutions

3,359

Shares Held

3.69B

Call Options Held

106M

Put Options Held

123M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $146B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody Lynn & Lieberson, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moody Lynn & Lieberson, LLC with notifications on news.

Account

Moody Lynn & Lieberson, LLC Pfizer Inc Transaction History